Earnings Report Card, Q1/12, Regenerative Medicine Universe – So far

Home > Dendreon (DNDN), Earnings Report Card, Geron (GERN), NASDAQ: TNGN, Quarterly Achievements, Quarterly Earnings, Tengion > Earnings Report Card, Q1/12, Regenerative Medicine Universe – So far

Earnings Report Card, Q1/12, Regenerative Medicine Universe – So far

May 8th, 2012 Henry McCusker Leave a comment Go to comments

Report Card … so far

An earnings release is a ‘report card’ of sorts for a public stem cell company. The current LPS (loss per share) standings reflect the universes’ investing status. By analyzing these comparisons, investors can begin to gauge the financial health versus the scientific opportunity of stem cell research and whether or not it deserves their investment.

Geron (GERN): http://www.scimitarequity.com/upload/GERN307282.pdf

Tengion (TNGN):http://www.scimitarequity.com/upload/TNGN%20Q1%20Earnings998632.pdf

Dendreon (DNDN): http://www.scimitarequity.com/upload/DNDN%20Q1%20Results229879.pdf

Share and Enjoy: These icons link to social bookmarking sites where readers can share and discover new web pages.